MACCHIA, LUIGI
 Distribuzione geografica
Continente #
AS - Asia 469
EU - Europa 431
NA - Nord America 363
SA - Sud America 161
AF - Africa 10
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.436
Nazione #
US - Stati Uniti d'America 346
SG - Singapore 241
BR - Brasile 132
IE - Irlanda 100
IT - Italia 91
CN - Cina 76
VN - Vietnam 60
DE - Germania 57
RU - Federazione Russa 54
HK - Hong Kong 52
CZ - Repubblica Ceca 34
SE - Svezia 17
FI - Finlandia 13
GB - Regno Unito 13
AR - Argentina 10
UA - Ucraina 9
CA - Canada 8
FR - Francia 8
ID - Indonesia 7
MX - Messico 7
TR - Turchia 7
BE - Belgio 6
IN - India 5
RS - Serbia 5
AT - Austria 4
ES - Italia 4
GR - Grecia 4
LT - Lituania 4
NL - Olanda 4
VE - Venezuela 4
CL - Cile 3
CO - Colombia 3
IR - Iran 3
PK - Pakistan 3
PY - Paraguay 3
SA - Arabia Saudita 3
BD - Bangladesh 2
EC - Ecuador 2
JP - Giappone 2
MY - Malesia 2
PL - Polonia 2
TN - Tunisia 2
UY - Uruguay 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
AL - Albania 1
AU - Australia 1
BO - Bolivia 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
IQ - Iraq 1
MA - Marocco 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
SC - Seychelles 1
SN - Senegal 1
TW - Taiwan 1
Totale 1.436
Città #
Dublin 100
Singapore 94
Dallas 68
Hong Kong 52
Ashburn 37
Munich 36
Beijing 34
New York 30
Santa Clara 29
Ho Chi Minh City 26
Chandler 25
Bari 22
Brno 17
Olomouc 17
Moscow 16
São Paulo 14
The Dalles 14
Boardman 13
Helsinki 12
Nyköping 12
Hanoi 9
London 9
Assago 8
Düsseldorf 7
Los Angeles 7
Brussels 6
Curitiba 6
Ann Arbor 5
Brooklyn 5
Jacksonville 5
Bologna 4
Can Tho 4
Council Bluffs 4
Falkenstein 4
Frankfurt am Main 4
Manfredonia 4
Porto Alegre 4
San Francisco 4
Toronto 4
Belgrade 3
Belo Horizonte 3
Chicago 3
Dearborn 3
Fortaleza 3
Istanbul 3
Kozani 3
Mexico City 3
Princeton 3
Rio de Janeiro 3
Seattle 3
Amsterdam 2
Ankara 2
Asunción 2
Bitonto 2
Biên Hòa 2
Boston 2
Campobasso 2
Caracas 2
Charlotte 2
Da Nang 2
Haiphong 2
Joinville 2
Karachi 2
Kashan 2
Kuala Lumpur 2
Maceió 2
Manaus 2
Mesagne 2
Milan 2
Monmouth Junction 2
Montevideo 2
Montreal 2
Nuremberg 2
Phoenix 2
Pune 2
Redwood City 2
Reggio Emilia 2
Rome 2
San Juan Bautista 2
Tashkent 2
Tunis 2
Uberaba 2
Abidjan 1
Afogados da Ingazeira 1
Almenno San Salvatore 1
Americana 1
Andover 1
Andradina 1
Annapolis 1
Antonina do Norte 1
Arapiraca 1
Araçatuba 1
Arrecife 1
Athens 1
Bandung 1
Banjarmasin 1
Barquisimeto 1
Barra Mansa 1
Batatais 1
Bekasi 1
Totale 886
Nome #
FOURIER TRANSFORM ION CYCLOTRON RESONANCE MASS SPECTROMETRY (FT-ICR-MS) FOR HIGH-RESOLUTION ANALYSIS OF FENNEL PROTEINS 121
Adult Renal Stem/Progenitor Cells Can Modulate T Regulatory Cells and Double Negative T Cells 102
Dermanyssus gallinae in città: serve un approccio multiattoriale in cui il veterinario è decisivo 100
When there is no communication between urban planners and public health operators: urban Dermanyssus gallinae infestations in humans 74
Wasp immunotherapy induced long-term and IgG4-independent protection 63
Dermanyssosis in the Urban Context: When the One Health Paradigm Is Put into Practice 59
Real-world experience with dupilumab in severe asthma: One-year data from an italian named patient program 58
Omalizumab nell'orticaria cronica spontanea: uno studio real-life su 14 pazienti 54
La disfunzione psicosomatica delle corde vocali 54
Studi su Omalizumab nella terapia dell'asma severo. Valutazione degli effetti sulla risposta immunologica IgE in vivo. Valutazione della tollerabilità 52
Reazioni ritardate a farmaci: dal test di proliferazione linfocitaria alla desensibilizzazione 51
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study 45
Comparison of evidence of treatment effects in randomized and nonrandomized studies on allergen immunotherapy 45
A Multicenter Study on the Prevalence of Clinical Patterns and Clinical Phenotypes in Adult Atopic Dermatitis 43
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab 43
Duration of chronic spontaneous urticaria remission after omalizumab discontinuation: A long-term observational study 42
Omalizumab in long-term treatment of refractory chronic spontaneus urticaria:effects of discontinuation 41
Dupilumab in atopic dermatitis: predictors of treatment outcome and time to response 41
Association between γ marker, human leucocyte antigens and killer immunoglobulin-like receptors and the natural course of human cytomegalovirus infection: a pilot study performed in a Sicilian population 41
Dupilumab elicits a favorable response in type-2 inflammatory comorbidities of severe atopic dermatitis 40
Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review 39
Two-year follow-up after drug desensitization in mucopolysaccharidosis 36
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 36
Desensitization in Iron Product Allergy 35
Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis 35
Planned omalizumab discontinuation in CSU management as a sustainable strategy: A 2‐year real‐life study 35
Benralizumab improves patient reported outcomes and functional parameters in difficult-to-treat patients with severe asthma: Data from a real-life cohort 32
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus 32
Immunological and non-immunological mechanisms of allergic diseases in the elderly: Biological and clinical characteristics 30
Use of Dupilumab for 543 Adult Patients with Moderate-To-Severe Atopic Dermatitis: A Multicenter, Retrospective Study 29
The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans 27
Totale 1.535
Categoria #
all - tutte 9.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.063


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 1 2 7 2 1 2
2021/202230 1 1 3 1 0 2 0 0 9 6 0 7
2022/2023162 10 9 5 5 12 18 4 14 64 4 9 8
2023/2024230 11 0 43 1 10 87 4 7 3 0 0 64
2024/2025477 21 4 18 10 35 51 40 39 122 29 51 57
2025/2026596 108 88 181 187 29 3 0 0 0 0 0 0
Totale 1.535